American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$460M |
| 2 |
Broadcom
AVGO
|
+$298M |
| 3 |
Sysco
SYY
|
+$225M |
| 4 |
MRSH
Marsh
MRSH
|
+$200M |
| 5 |
Ascendis Pharma A/S
ASND
|
+$186M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$573M |
| 2 |
Visa
V
|
+$465M |
| 3 |
Apple
AAPL
|
+$461M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$363M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$358M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.8% |
| 2 | Financials | 13.6% |
| 3 | Consumer Discretionary | 12.52% |
| 4 | Industrials | 10.05% |
| 5 | Healthcare | 9.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITIC
2376
Investors Title Co
ITIC
$534M
| $814K | ﹤0.01% |
3,260
-5,074
| -61% | -$1.33M |
|
2377
Nurix Therapeutics
NRIX
$2.82B
| $813K | ﹤0.01% |
42,878
+16,760
| +64% | +$241K |
|
2378
NVE Corp
NVEC
$563M
| $808K | ﹤0.01% |
13,626
-405
| -3% | -$27.1K |
|
2379
Franklin Covey
FC
$227M
| $808K | ﹤0.01% |
48,129
+17,324
| +56% | +$290K |
|
2380
Interparfums
IPAR
$3.7B
| $801K | ﹤0.01% |
9,448
+4,375
| +86% | +$385K |
|
2381
Remitly
RELY
$5.39B
| $799K | ﹤0.01% |
57,928
+1,247
| +2% | +$18.1K |
|
2382
Primis Financial Corp
FRST
$413M
| $795K | ﹤0.01% |
57,130
+1,062
| +2% | +$12K |
|
2383
ODDITY Tech
ODD
$615M
| $794K | ﹤0.01% |
19,762
-475
| -2% | -$21.5K |
|
2384
Eagle Bancorp Montana
EBMT
$189M
| $788K | ﹤0.01% |
39,622
| – | – |
|
2385
NRC Health Common Stock
NRC
$471M
| $786K | ﹤0.01% |
41,862
+898
| +2% | +$13.6K |
|
2386
GameStop
GME
$8.33B
| $783K | ﹤0.01% |
38,971
+1,586
| +4% | +$35.6K |
|
2387
Casella Waste Systems
CWST
$5.79B
| $781K | ﹤0.01% |
7,973
+371
| +5% | +$34.4K |
|
2388
Shutterstock
SSTK
$217M
| $779K | ﹤0.01% |
40,792
+8
| +0% | +$171 |
|
|
SRTA
2389
Strata Critical Medical Inc
SRTA
$528M
| $775K | ﹤0.01% |
161,070
+8,521
| +6% | +$41.2K |
|
2390
Entrada Therapeutics
TRDA
$290M
| $774K | ﹤0.01% |
75,282
-112
| -0.1% | -$944 |
|
2391
AeroVironment
AVAV
$9.59B
| $771K | ﹤0.01% |
3,187
+758
| +31% | +$238K |
|
2392
Artesian Resources
ARTNA
$369M
| $764K | ﹤0.01% |
24,157
-297
| -1% | -$9.57K |
|
2393
Triple Flag Precious Metals
TFPM
$6.45B
| $762K | ﹤0.01% |
22,931
-100,243
| -81% | -$3.14M |
|
2394
ARKO Corp
ARKO
$505M
| $757K | ﹤0.01% |
166,697
-278
| -0.2% | -$1.25K |
|
2395
E.W. Scripps
SSP
$310M
| $754K | ﹤0.01% |
188,973
-476
| -0.3% | -$1.6K |
|
2396
Prothena Corp
PRTA
$466M
| $753K | ﹤0.01% |
78,804
+6,565
| +9% | +$66.8K |
|
2397
Albertsons Companies
ACI
$6.02B
| $751K | ﹤0.01% |
43,762
| – | – |
|
2398
Keros Therapeutics
KROS
$211M
| $746K | ﹤0.01% |
36,640
-2,526
| -6% | -$44.3K |
|
|
FRGE
2399
DELISTED
Forge Global Holdings
FRGE
| $745K | ﹤0.01% |
16,729
+2,661
| +19% | +$89.9K |
|
2400
Boston Omaha
BOC
$431M
| $743K | ﹤0.01% |
60,038
-1,885
| -3% | -$24.5K |
|
Similar funds
American Century Companies's Q4 2025 Portfolio in Review
As of Q4 2025, American Century Companies held 2,902 positions worth $199B, up 1.2% from $197B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
American Century Companies's Q4 2025 filing shows 123 new, 1,653 increased, 947 reduced and 91 closed positions. Its largest new stake was Amrize Ltd: 2,173,524 shares worth $118M. The largest sale was NVIDIA, an estimated $573M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- American Century Companies's largest Q4 2025 buy was Amrize Ltd: 2,173,524 shares worth $118M.
- American Century Companies added most to Amphenol in Q4 2025, an estimated $460M increase.
- American Century Companies's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $573M.
- American Century Companies fully exited Premier in Q4 2025, selling an estimated $91.5M.
- American Century Companies's ten largest holdings make up 27% of its $199B portfolio in Q4 2025.
- American Century Companies opened 123 new positions and closed 91 in Q4 2025.
- American Century Companies's portfolio value rose 1.2% quarter-over-quarter to $199B.
Based on American Century Companies's 13F filing for Q4 2025, filed 13 Feb 2026.